Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs

Vista sencilla de ítem
dc.contributor.authorEspinosa‑Saez, Roger
dc.contributor.authorRobledo, Sara M.
dc.contributor.authorPineda, Tatiana
dc.contributor.authorMurillo, Javier
dc.contributor.authorZúñiga, César
dc.contributor.authorYañez, Osvaldo
dc.contributor.authorCantero‑López, Plinio
dc.contributor.authorSaez‑Vega, Alex
dc.contributor.authorGuzmán‑Teran, Camilo
dc.date.accessioned2023-10-25T16:14:39Z
dc.date.available2023-10-25T16:14:39Z
dc.date.issued2023-12
dc.descriptionIndexación: Scopuses
dc.description.abstractIn this study, six analogs of 2-arylquinoline were synthesized and evaluated for their in vitro and in vivo antiplasmodial and leishmanicidal activity. At a later stage, hemolytic activity and druggability were tested in vitro and in silico, respectively, observing as a result: firstly, compounds showed half-maximal effective concentration (EC50) values between 3.6 and 19.3 µM. Likewise, a treatment using the compounds 4a–f caused improvement in most of the treated hamsters and cured some of them. Regarding the antiplasmodial activity, the compounds showed moderate to high activity, although they did not show hemolytic activity. Furthermore, 4e and 4f compounds were not able to control P. berghei infection when administered to animal models. Molecular dynamic simulations, molecular docking and ligand binding affinity indicate good characteristics of the studied compounds, which are expected to be active. And lastly, the compounds are absorbable at the hematoencephalic barrier but not in the gastrointestinal tract. In summary, ADMET properties suggest that these molecules may be used as a safe treatment against Leishmania.es
dc.identifier.citationScientific Reports Volume 13, Issue 1 December 2023 Article number 17523es
dc.identifier.doi10.1038/s41598-023-43805-4en
dc.identifier.issn2045-2322
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/53618
dc.language.isoenes
dc.publisherNature Researches
dc.rights.licenseCC BY 4.0 DEED Atribución 4.0 Internacionalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.esen
dc.titleScreening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogses
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
s41598-023-43805-4.pdf
Tamaño:
1.46 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
FCE - Artículos de Revista